Correll, Christoph U.

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Kishimoto, T., Hagi, K., Kurokawa, S., Kane, J. M., & Correll, C. U. (2021) · The Lancet Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 369

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 359

Single-dose infusion ketamine and non-ketamine N -methyl- d -aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 359

What is good mental health? A scoping review

Fusar-Poli, P., Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., et al. (2020) · European Neuropsychopharmacology

Psychological Well-being and Life SatisfactionChild and Adolescent Psychosocial and Emotional Development

Cited by 356

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine

Schizophrenia research and treatmentHealth Promotion and Cardiovascular Prevention

Cited by 332

What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?

Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 324

Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects

Solmi, M., Fornaro, M., Ostinelli, E. G., Zangani, C., Croatto, G., Monaco, F., Krinitski, D., Fusar‐Poli, P., & Correll, C. U. (2020) · World Psychiatry

Pharmaceutical studies and practicesAttention Deficit Hyperactivity Disorder

Cited by 324

Towards a youth mental health paradigm: a perspective and roadmap

Uhlhaas, P. J., Davey, C. G., Mehta, U. M., Shah, J., Torous, J., Allen, N. B., Avenevoli, S., Bella-Awusah, T., Chanen, A., Chen, E. Y. H., et al. (2023) · Molecular Psychiatry

Child and Adolescent Psychosocial and Emotional DevelopmentPsychology and Mental Health

Cited by 318

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables

Vancampfort, D., Correll, C. U., Wampers, M., Sienaert, P., Mitchell, A. J., De Herdt, A., Probst, M., Scheewe, T. W., & De Hert, M. (2014) · Psychological Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsCardiac Health and Mental Health

Cited by 317

Measurement-based care versus standard care for major depression: A randomized controlled trial with blind raters

Guo, T., Xiang, Y.-T., Xiao, L., Hu, C.-Q., Chiu, H. F. K., Ungvari, G. S., Correll, C. U., Lai, K. Y. C., Feng, L., Geng, Y., et al. (2015) · American Journal of Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 308

The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses

Haddad, P. M., & Correll, C. U. (2018) · Therapeutic Advances in Psychopharmacology

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 259

Clinical predictors of therapeutic response to antipsychotics in schizophrenia

Carbon, M., & Correll, C. U. (2014) · Dialogues in Clinical Neuroscience

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 257

Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo‐controlled trials

Correll, C. U., Sheridan, E. M., & DelBello, M. P. (2010) · Bipolar Disorders

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 255

Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis

Carrión, R. E., McLaughlin, D., Goldberg, T. E., Auther, A. M., Olsen, R. H., Olvet, D. M., Correll, C. U., & Cornblatt, B. A. (2013) · JAMA Psychiatry

Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending

Cited by 250

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Svensson, C. K., Koyuncu, K., Schjerning, O., Oturai, P. S., Kjaer, A., et al. (2017) · JAMA Psychiatry

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 250

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years

Vermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P. J., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019) · Schizophrenia Bulletin

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 246

The impact of pharmacological and non‐pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta‐review of meta‐analyses of randomized controlled trials

Vancampfort, D., Firth, J., Correll, C. U., Solmi, M., Siskind, D., De Hert, M., Carney, R., Koyanagi, A., Carvalho, A. F., Gaughran, F., et al. (2019) · World Psychiatry

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 227

Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries

Solmi, M., Song, M., Yon, D. K., Lee, S. W., Fombonne, E., Kim, M. S., Park, S., Lee, M. H., Hwang, J., Keller, R., et al. (2022) · Molecular Psychiatry

Autism Spectrum Disorder ResearchMental Health Treatment and Access

Cited by 226

Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review

Dragioti, E., Solmi, M., Favaro, A., Fusar-Poli, P., Dazzan, P., Thompson, T., Stubbs, B., Firth, J., Fornaro, M., Tsartsalis, D., et al. (2019) · JAMA Psychiatry

Treatment of Major DepressionPharmacovigilance and Adverse Drug Reactions

Cited by 215

Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

Carbon, M., Kane, J. M., Leucht, S., & Correll, C. U. (2018) · World Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 214

Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence

Correll, C. U., Rubio, J. M., Inczedy-Farkas, G., Birnbaum, M. L., Kane, J. M., & Leucht, S. (2017) · JAMA Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 214

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

Kane, J. M., Schooler, N. R., Marcy, P., Correll, C. U., Achtyes, E. D., Gibbons, R. D., & Robinson, D. G. (2020) · JAMA psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 208

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

Nielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology

Schizophrenia research and treatmentDiabetes Treatment and Management

Cited by 207

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Correll, C. U., Kim, E., Sliwa, J. K., Hamm, W., Gopal, S., Mathews, M., Venkatasubramanian, R., & Saklad, S. R. (2021) · CNS Drugs

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 205